We are live on ! Find out more
PLXP

PLx Pharma Inc. Common Stock
PLXP

Delisted

PLXP was delisted on the 12th of April, 2023.

Back to rankings

14 hedge funds and large institutions have $3.25M invested in PLx Pharma Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% less funds holding

Funds holding: 18 → 14 (-4)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

63% less capital invested

Capital invested by funds: $8.79M → $3.25M (-$5.55M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
+$1.42M
2
Renaissance Technologies
Renaissance Technologies
New York
+$7.13K
3
BlackRock
BlackRock
New York
+$1.14K

Top Sellers

Rank Fund Capital Flow
1
HIIFS
Harel Insurance Investments & Financial Services
Israel
-$1.07M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$242K
3
Millennium Management
Millennium Management
New York
-$103K
4
CH
CVI Holdings
Delaware
-$56K
5
Goldman Sachs
Goldman Sachs
New York
-$50.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$2.25M +$1.42M +397,495 +37%
HIIFS
2
Harel Insurance Investments & Financial Services
Israel
$383K -$1.07M -300,000 -55%
Vanguard Group
3
Vanguard Group
Pennsylvania
$146K -$242K -67,956 -42%
Brown Advisory
4
Brown Advisory
Maryland
$114K -$1.43K -400 -0.5%
UOTTAIMCU
5
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$96K – – –
Millennium Management
6
Millennium Management
New York
$88K -$103K -28,996 -34%
Renaissance Technologies
7
Renaissance Technologies
New York
$67K +$7.13K +2,000 +5%
Goldman Sachs
8
Goldman Sachs
New York
$30K -$50.9K -14,263 -42%
Fayez Sarofim & Co
9
Fayez Sarofim & Co
Texas
$21K – – –
UBS Group
10
UBS Group
Switzerland
$19K -$2.74K -769 -6%
CWM
11
Cranbrook Wealth Management
Michigan
$11K – – –
Wells Fargo
12
Wells Fargo
California
$9K -$17.8K -5,000 -45%
BlackRock
13
BlackRock
New York
$7K +$1.14K +320 +8%
CH
14
CVI Holdings
Delaware
– -$56K -13,878 Closed
HWA
15
Heritage Way Advisors
Illinois
– -$49K -12,000 Closed
Deutsche Bank
16
Deutsche Bank
Germany
– -$17K -4,205 Closed
PAM
17
Panagora Asset Management
Massachusetts
– -$7K -1,613 Closed

PLXP Hedge Fund Activity: Q4 2018 in Review

14 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q4 2018, worth a combined $3.25M — down 63% from $8.79M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PLXP and 0 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 3 added.

The largest buyer was Park West Asset Management, adding an estimated $1.42M. The largest seller was Harel Insurance Investments & Financial Services, cutting an estimated $1.07M.

  • 14 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q4 2018, down from 18 in Q3 2018.
  • Funds reported $3.25M of PLx Pharma Inc. Common Stock stock for Q4 2018, down 63% quarter-over-quarter.
  • 0 funds opened new PLx Pharma Inc. Common Stock positions in Q4 2018 and 4 closed out, a net change of -4 holders.
  • The largest PLx Pharma Inc. Common Stock buyer in Q4 2018 was Park West Asset Management, an estimated $1.42M added.
  • The largest PLx Pharma Inc. Common Stock seller in Q4 2018 was Harel Insurance Investments & Financial Services, an estimated $1.07M sold.

Based on aggregated 13F filings for Q4 2018.